(4-Bromo-2-methanesulfonylphenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone → HCID 71252051, compound

HRID 2411430Notes

Reaction equation

HRID 2411430 reaction equation
[CH3:1][C@@H:2]1[CH2:6][S:5](=[O:8])(=[O:7])[NH:4][CH2:3]1.Br[C:10]1[CH:15]=[CH:14][C:13]([C:16]([N:18]2[CH2:23][CH2:22][N:21]([C:24]3[C:29]([CH3:30])=[CH:28][C:27]([CH3:31])=[CH:26][N:25]=3)[CH2:20][CH2:19]2)=[O:17])=[C:12]([S:32]([CH3:35])(=[O:34])=[O:33])[CH:11]=1>>[CH3:30][C:29]1[C:24]([N:21]2[CH2:22][CH2:23][N:18]([C:16]([C:13]3[CH:14]=[CH:15][C:10]([N:4]4[CH2:3][C@H:2]([CH3:1])[CH2:6][S:5]4(=[O:8])=[O:7])=[CH:11][C:12]=3[S:32]([CH3:35])(=[O:34])=[O:33])=[O:17])[CH2:19][CH2:20]2)=[N:25][CH:26]=[C:27]([CH3:31])[CH:28]=1

Participants

3

Procedure

Using (S)-4-methylisothiazolidine 1,1-dioxide (100 mg) described in Preparation Example 4 and (4-bromo-2-methanesulfonylphenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (220 mg) described in Preparation Example 112 and by the reaction and treatment in the same manner as in Example 4, the title compound (49 mg) was obtained.

Workup

  1. customdescribed in Preparation Example 112 and by the reaction and treatment in the same manner as in Example 4

Sources & evidence

ORD record
ord-33c1ddca91194e8d98e32f719f037768
Source dataset
uspto-grants-2014_08
Patent number
US08816079B2

Reaction notes

Loading…